EP
DXCM icon

Eversept Partners’s DexCom DXCM Stock Holding History

Eversept Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-148,688
Closed -$11.6M – 62
2024
Q4 		$11.6M Buy
+148,688
New +$11M 1.03% 22
2022
Q3 		– Sell
-14,468
Closed -$1.08M – 78
2022
Q2 		$1.08M Sell
14,468
-99,148
-87% -$9.05M 0.08% 64
2022
Q1 		$14.5M Buy
113,616
+88,012
+344% +$9.63M 1.12% 27
2021
Q4 		$3.44M Hold
25,604
– – 0.22% 70
2021
Q3 		$3.5M Sell
25,604
-12,496
-33% -$1.58M 0.24% 60
2021
Q2 		$4.07M Sell
38,100
-36,864
-49% -$3.54M 0.27% 52
2021
Q1 		$6.74M Buy
74,964
+65,072
+658% +$6.11M 0.35% 44
2020
Q4 		$914K Buy
+9,892
New +$883K 0.11% 51
2020
Q3 		– Sell
-26,680
Closed -$2.7M – 58
2020
Q2 		$2.7M Sell
26,680
-51,468
-66% -$4.6M 0.37% 41
2020
Q1 		$5.26M Buy
78,148
+29,948
+62% +$1.86M 1.31% 18
2019
Q4 		$2.64M Sell
48,200
-130,000
-73% -$6.17M 0.47% 40
2019
Q3 		$6.65M Buy
+178,200
New +$6.92M 2.06% 14

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Eversept Partners's DXCM Position: Q1 2025 in Review

Eversept Partners sold out of DexCom (DXCM) in Q1 2025, closing a stake of 148,688 shares — an estimated $11.6M sold.

Eversept Partners first reported a position in DXCM in Q3 2019 and held it in 12 quarters. The position peaked at $14.5M in Q1 2022. 933 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Eversept Partners reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Eversept Partners sold 148,688 DexCom shares in Q1 2025, an estimated $11.6M.
  • Eversept Partners first reported a position in DexCom in Q3 2019 and held it in 12 quarters.
  • Eversept Partners's DexCom position peaked at $14.5M in Q1 2022.
  • 933 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Eversept Partners's 13F filing for Q1 2025, filed 15 May 2025.